Research Output per year
Research Output 2005 2019
2010
The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia
Mahipal, A. & Weiss, M., Nov 1 2010, In : Current Oncology Reports. 12, 6, p. 352-354 3 p.Research output: Contribution to journal › Comment/debate
B-Cell Chronic Lymphocytic Leukemia
Cyclophosphamide
Disease-Free Survival
Rituximab
fludarabine